用于报告宫颈/阴道细胞学诊断的贝塞斯达系统：1991年4月29 - 30日第二次美国国立癌症研究所研讨会后修订。 - Suppr

Suppr

超能文献

The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991.

出版信息

Acta Cytol. 1993 Mar-Apr;37(2):115-24.

PMID:8465628

Abstract

摘要

相似文献

The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991.用于报告宫颈/阴道细胞学诊断的贝塞斯达系统：1991年4月29 - 30日第二次美国国立癌症研究所研讨会后修订。

Acta Cytol. 1993 Mar-Apr;37(2):115-24.

The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop.《宫颈/阴道细胞学诊断报告的修订贝塞斯达系统：1991年贝塞斯达研讨会报告》

J Reprod Med. 1992 May;37(5):383-6.

The 1988 Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. Developed and approved at a National Cancer Institute Workshop, Bethesda, Maryland, U.S.A., December 12-13, 1988.1988年贝塞斯达宫颈/阴道细胞学诊断报告系统。由美国国立癌症研究所研讨会制定并批准，地点为美国马里兰州贝塞斯达，时间为1988年12月12日至13日。

J Reprod Med. 1989 Oct;34(10):779-85.

The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and approved at the National Cancer Institute Workshop in Bethesda, Maryland, December 12-13, 1988.1988年贝塞斯达宫颈/阴道细胞学诊断报告系统：于1988年12月12日至13日在马里兰州贝塞斯达的国家癌症研究所研讨会上制定并批准。

Hum Pathol. 1990 Jul;21(7):704-8. doi: 10.1016/0046-8177(90)90029-5.

The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and approved at the National Cancer Institute workshop in Bethesda, MD, December 12-13, 1988.1988年贝塞斯达宫颈/阴道细胞学诊断报告系统：于1988年12月12日至13日在马里兰州贝塞斯达的国家癌症研究所研讨会上制定并批准。

Diagn Cytopathol. 1989;5(3):331-4. doi: 10.1002/dc.2840050318.

The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. Developed and approved at a National Cancer Institute Workshop, Bethesda, Maryland, U.S.A., December 12-13, 1988.1988年贝塞斯达系统用于报告宫颈/阴道细胞学诊断结果。由美国国立癌症研究所研讨会制定并批准，该研讨会于1988年12月12日至13日在美国马里兰州贝塞斯达举行。

Anal Quant Cytol Histol. 1989 Oct;11(5):291-7.

The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop.1988年贝塞斯达宫颈/阴道细胞学诊断报告系统。国家癌症研究所研讨会。

JAMA. 1989 Aug 18;262(7):931-4.

The Bethesda System for reporting cervical/vaginal cytologic diagnosis: an overview.

Int J Gynecol Pathol. 1991;10(4):323-5. doi: 10.1097/00004347-199110000-00003.

The Bethesda System for reporting cervical and vaginal cytologic diagnoses: report of the 1991 Bethesda workshop.

J Fam Pract. 1992 Jul;35(1):98-101.

[Differential diagnostic possibilities based on algorithms from histological study in cervical and vaginal diseases].

Arkh Patol. 1981;43(11):81-5.

引用本文的文献

Histological Follow-Up in Patients with Atypical Glandular Cells on Pap Smears.巴氏涂片检查显示非典型腺细胞患者的组织学随访

J Cytol. 2017 Oct-Dec;34(4):203-207. doi: 10.4103/JOC.JOC_209_16.

Clinicopathological significance of atypical glandular cells on Pap smear.巴氏涂片检查中不典型腺细胞的临床病理意义

Obstet Gynecol Sci. 2013 Mar;56(2):76-83. doi: 10.5468/OGS.2013.56.2.76. Epub 2013 Mar 12.

Clinical implications of the cervical Papanicolaou test results in the management of anal warts in HIV-infected women.宫颈巴氏试验结果在HIV感染女性尖锐湿疣管理中的临床意义。

PLoS One. 2013 Nov 28;8(11):e81751. doi: 10.1371/journal.pone.0081751. eCollection 2013.

Cells and the (imaginary) patient: the multistable practitioner-technology-cell interface in the cytology laboratory.

Med Health Care Philos. 2012 Aug;15(3):295-308. doi: 10.1007/s11019-011-9325-0.

Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.碳酸酐酶IX和人乳头瘤病毒作为细胞学诊断为非典型腺细胞的女性宫颈发育异常/肿瘤形成的诊断生物标志物：美国妇科肿瘤学组的一项研究

Int J Cancer. 2009 Nov 15;125(10):2434-40. doi: 10.1002/ijc.24615.

Collection of the BD SurePath Pap Test with a broom device plus endocervical brush improves disease detection when compared to the broom device alone or the spatula plus endocervical brush combination.与单独使用扫帚装置或刮板加宫颈管刷组合相比，使用扫帚装置加宫颈管刷收集BD SurePath巴氏试验可提高疾病检测率。

Cytojournal. 2008 Feb 12;6:4. doi: 10.4103/1742-6413.45495.

Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection.醋酸甲羟孕酮长效注射剂及复方口服避孕药的使用与致癌性人乳头瘤病毒感染女性的宫颈肿瘤形成

Am J Obstet Gynecol. 2009 May;200(5):489.e1-8. doi: 10.1016/j.ajog.2009.01.030.

Do women >or=50 years of age need as much screening as women <50 years after they have had negative screening results?50岁及以上的女性在筛查结果为阴性后，需要和50岁以下的女性进行同样多的筛查吗？

Br J Cancer. 2008 Jul 22;99(2):239-44. doi: 10.1038/sj.bjc.6604455. Epub 2008 Jul 1.

A methodological framework to distinguish spectrum effects from spectrum biases and to assess diagnostic and screening test accuracy for patient populations: application to the Papanicolaou cervical cancer smear test.一种区分光谱效应与光谱偏差并评估患者群体诊断和筛查测试准确性的方法框架：应用于巴氏宫颈癌涂片检查

BMC Med Res Methodol. 2008 Feb 21;8:7. doi: 10.1186/1471-2288-8-7.

Human papillomavirus in endometrial adenocarcinomas: infectious agent or a mere "passenger"?子宫内膜腺癌中的人乳头瘤病毒：感染因子还是单纯的“过客”？

Infect Dis Obstet Gynecol. 2007;2007:60549. doi: 10.1155/2007/60549.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验